Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. Its flagship product is Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous fluid administration for achieving hydration to enhance the dispersion and absorption of other injected drugs in subcutaneous urography and to improve resorption of radiopaque agents. The company also develops Perjeta; RITUXAN HYCELA and MabThera SC for the treatment of non-Hodgkin lymphoma and chronic lymphocytic leukemia (CLL); RITUXAN SC for patients with CLL; and HYQVIA for the treatment of immunodeficiency disorders. In addition, it is developing Tecentriq for non-small cell lung cancer; OCREVUS for multiple sclerosis; DARZALEX for the treatment of patients with amyloidosis, smoldering myeloma, and multiple myeloma; nivolumab for the treatment of solid tumors; ARGX-113, a human neonatal Fc receptor; ARGX-117 to treat autoimmune diseases; and BMS-986179, an anti-CD-73 antibody. The company has collaborations with F. Hoffmann-La Roche, Ltd.; Hoffmann-La Roche, Inc.; Baxalta US Inc.; Baxalta GmbH; Pfizer Inc.; Janssen Biotech, Inc.; AbbVie, Inc.; Eli Lilly and Company; Bristol-Myers Squibb Company; Alexion Pharma Holding; ARGENX BVBA; Horizon Therapeutics plc; National Institute of Allergy and Infectious Diseases; Centre for the AIDS Programme of Research in South Africa; and ViiV Healthcare Limited for small and large molecule targets for the treatment and prevention of HIV. Halozyme Therapeutics, Inc. was founded in 1998 and is based in San Diego, California. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Halozyme Therapeutics Inc..
Halozyme Therapeutics Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Halozyme Therapeutics Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Halozyme Therapeutics Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Halozyme Therapeutics Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Halozyme Therapeutics Inc. and all latest updates of the company are provided.
The 2025 version of Halozyme Therapeutics Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Halozyme Therapeutics Inc.- Key Facts
2.2 Halozyme Therapeutics Inc.- Geographic Locations
2.3 Halozyme Therapeutics Inc.- Subsidiaries and Affiliates
2.4 Halozyme Therapeutics Inc.- Business Divisions
2.5 Halozyme Therapeutics Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Halozyme Therapeutics Inc. Strategic Analysis Review
3.1 Halozyme Therapeutics Inc.- Key Strategies
3.2 Halozyme Therapeutics Inc.- Company Outlook Statement
3.3 Halozyme Therapeutics Inc.- SWOT Analysis
3.3.1 Halozyme Therapeutics Inc.- Key Strengths
3.3.2 Halozyme Therapeutics Inc.- Key Weaknesses
3.3.3 Halozyme Therapeutics Inc.- Potential Opportunities
3.3.4 Halozyme Therapeutics Inc.- Potential Threats
3.4 Halozyme Therapeutics Inc.- Key Competitors
4. Business Description of the Company
4.1 Halozyme Therapeutics Inc.- Business Overview
4.2 Halozyme Therapeutics Inc.- Operations by Segment
5 Products and Services Details
5.1 Halozyme Therapeutics Inc.- Key Products
5.2 Halozyme Therapeutics Inc.- Key Service Areas
5.3 Halozyme Therapeutics Inc.- Key Brands
6 Company Developments
6.1 Halozyme Therapeutics Inc.- Company History
6.2 Halozyme Therapeutics Inc.- Latest Developments
7 Financial Analysis
7.1 Halozyme Therapeutics Inc.- Income Statements
7.2 Halozyme Therapeutics Inc.- Balance Sheet
7.3 Halozyme Therapeutics Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Halozyme Therapeutics Inc.- Direct Competitors
8.2 Halozyme Therapeutics Inc.- Competitor Financial Ratios comparison
8.3 Halozyme Therapeutics Inc.- Competitor Stock Charts Comparison
8.4 Halozyme Therapeutics Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
